Investigation of SCWorx Corp.

SCWorx Corp. (WORX) Accused of Misleading Shareholders 

On April 13, 2020, SCWorx announced it had received a committed purchase order of two million COVID-19 rapid testing kits, “with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week.” On this news, SCWorx’s share price experienced an impressive 81% increase, closing at $12.02 per share. Then, on April 17, 2020, Hindenburg Research issued a report doubting the validity of the deal, calling it “completely bogus” and stating the test supplier was “laden with red flags” and that the CEO allegedly “falsified his medical credentials.” On this news, SCWorx’s share price fell $1.19 per share, or more than 17%, over three consecutive trading sessions to close at $5.76 per share on April 21, 2020. Consequently, on April 22, 2020, the SEC halted trading of the Company’s stock. Trading of the stock has remained halted since.

If you purchased SCWorx Corp. (WORX) securities between April 13, 2020 and April 17, 2020, you have until June 29, 2020, to ask the court to be appointed lead plaintiff for the class.

Send us a message for more information.

Protect your investments.

Sign up for free investment monitoring.

Stock Watch members receive free investment monitoring and notifications.  

Leave your details to get started

"*" indicates required fields

Ticker + Amount
This field is for validation purposes and should be left unchanged.

Skip to content